Vectored delivery of TNFα culminated in TNFerade, a replication incompetent adenoviral vector, which was studied in a randomized phase 3 trial in combination with fluorouracil and radiotherapy, for the treatment of locally advanced pancreatic cancer. The gene discussed is TNF; the disease is familial pancreatic carcinoma.